» Articles » PMID: 33478949

Severely Ill COVID-19 Patients Display Impaired Exhaustion Features in SARS-CoV-2-reactive CD8 T Cells

Overview
Journal Sci Immunol
Date 2021 Jan 22
PMID 33478949
Citations 139
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular properties of CD8 T cells that respond to SARS-CoV-2 infection are not fully known. Here, we report on the single-cell transcriptomes of >80,000 virus-reactive CD8 T cells, obtained using a modified Antigen-Reactive T cell Enrichment (ARTE) assay, from 39 COVID-19 patients and 10 healthy subjects. COVID-19 patients segregated into two groups based on whether the dominant CD8 T cell response to SARS-CoV-2 was 'exhausted' or not. SARS-CoV-2-reactive cells in the exhausted subset were increased in frequency and displayed lesser cytotoxicity and inflammatory features in COVID-19 patients with mild compared to severe illness. In contrast, SARS-CoV-2-reactive cells in the dominant non-exhausted subset from patients with severe disease showed enrichment of transcripts linked to co-stimulation, pro-survival NF-κB signaling, and anti-apoptotic pathways, suggesting the generation of robust CD8 T cell memory responses in patients with severe COVID-19 illness. CD8 T cells reactive to influenza and respiratory syncytial virus from healthy subjects displayed polyfunctional features and enhanced glycolysis. Cells with such features were largely absent in SARS-CoV-2-reactive cells from both COVID-19 patients and healthy controls non-exposed to SARS-CoV-2. Overall, our single-cell analysis revealed substantial diversity in the nature of CD8 T cells responding to SARS-CoV-2.

Citing Articles

Effector CD8 T cell differentiation in primary and breakthrough SARS-CoV-2 infection in mice.

Kingstad-Bakke B, Lee W, Yount Jr B, Cleven T, Park H, Sullivan J Commun Biol. 2025; 8(1):392.

PMID: 40057586 PMC: 11890755. DOI: 10.1038/s42003-025-07820-7.


Bronchoalveolar lavage single-cell transcriptomics reveals immune dysregulations driving COVID-19 severity.

Asaba C, Bitazar R, Labonte P, Bukong T PLoS One. 2025; 20(2):e0309880.

PMID: 39928675 PMC: 11809808. DOI: 10.1371/journal.pone.0309880.


Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19.

Guironnet-Paquet A, Hamzeh-Cognasse H, Berard F, Cognasse F, Richard J, Yonis H Front Immunol. 2025; 15:1492672.

PMID: 39896810 PMC: 11782122. DOI: 10.3389/fimmu.2024.1492672.


Robust mucosal SARS-CoV-2-specific T cells effectively combat COVID-19 and establish polyfunctional resident memory in patient lungs.

Zhu A, Chen Z, Yan Q, Jiang M, Liu X, Li Z Nat Immunol. 2025; 26(3):459-472.

PMID: 39875584 PMC: 11876067. DOI: 10.1038/s41590-024-02072-9.


Distinct CD8 T-cell types Associated with COVID-19 Severity in Unvaccinated HLA-A2 Patients.

Masuda K, Iketani S, Liu L, Huang J, Qiao Y, Shah J bioRxiv. 2025; .

PMID: 39868279 PMC: 11761488. DOI: 10.1101/2025.01.12.632164.


References
1.
Soskic B, Cano-Gamez E, Smyth D, Rowan W, Nakic N, Esparza-Gordillo J . Chromatin activity at GWAS loci identifies T cell states driving complex immune diseases. Nat Genet. 2019; 51(10):1486-1493. PMC: 6872452. DOI: 10.1038/s41588-019-0493-9. View

2.
Daamen A, Bachali P, Owen K, Kingsmore K, Hubbard E, Labonte A . Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway. Sci Rep. 2021; 11(1):7052. PMC: 8007747. DOI: 10.1038/s41598-021-86002-x. View

3.
Simeonov D, Gowen B, Boontanrart M, Roth T, Gagnon J, Mumbach M . Discovery of stimulation-responsive immune enhancers with CRISPR activation. Nature. 2017; 549(7670):111-115. PMC: 5675716. DOI: 10.1038/nature23875. View

4.
Thommen D, Koelzer V, Herzig P, Roller A, Trefny M, Dimeloe S . A transcriptionally and functionally distinct PD-1 CD8 T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade. Nat Med. 2018; 24(7):994-1004. PMC: 6110381. DOI: 10.1038/s41591-018-0057-z. View

5.
Su L, Pan P, Yan P, Long Y, Zhou X, Wang X . Role of vimentin in modulating immune cell apoptosis and inflammatory responses in sepsis. Sci Rep. 2019; 9(1):5747. PMC: 6451033. DOI: 10.1038/s41598-019-42287-7. View